These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25403919)

  • 21. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
    Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables.
    Maki KC; Bobotas G; Dicklin MR; Huebner M; Keane WF
    J Clin Lipidol; 2017; 11(1):102-109. PubMed ID: 28391875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults.
    Moosavi D; Vuckovic I; Kunz HE; Lanza IR
    J Nutr; 2022 Jul; 152(7):1675-1689. PubMed ID: 35389487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.
    Oscarsson J; Önnerhag K; Risérus U; Sundén M; Johansson L; Jansson PA; Moris L; Nilsson PM; Eriksson JW; Lind L
    J Clin Lipidol; 2018; 12(6):1390-1403.e4. PubMed ID: 30197273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
    Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response of n-3 polyunsaturated fatty acids on lipid profile and tolerability in mildly hypertriglyceridemic subjects.
    Park Y; Harris WS
    J Med Food; 2009 Aug; 12(4):803-8. PubMed ID: 19735180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia.
    Maki KC; McKenney JM; Reeves MS; Lubin BC; Dicklin MR
    Am J Cardiol; 2008 Aug; 102(4):429-33. PubMed ID: 18678300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medium- and long-chain fatty acid triacylglycerol reduce body fat and serum triglyceride in overweight and hypertriglyceridemic subjects].
    Zhang YH; Liu YH; Zheng ZX; Wang J; Zhang Y; Zhang RX; Yu XM; Jing HJ; Xue CY; Wu J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep; 43(9):765-71. PubMed ID: 20137557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects.
    Asakura L; Lottenberg AM; Neves MQ; Nunes VS; Rocha JC; Passarelli M; Nakandakare ER; Quintão EC
    Am J Clin Nutr; 2000 Mar; 71(3):701-5. PubMed ID: 10702162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic β-cell response in subjects with primary hypertriglyceridemia.
    Maki KC; Lawless AL; Kelley KM; Dicklin MR; Schild AL; Rains TM
    Prostaglandins Leukot Essent Fatty Acids; 2011; 85(3-4):143-8. PubMed ID: 21775113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between polymorphisms in phospholipase A2 genes and the plasma triglyceride response to an n-3 PUFA supplementation: a clinical trial.
    Tremblay BL; Cormier H; Rudkowska I; Lemieux S; Couture P; Vohl MC
    Lipids Health Dis; 2015 Feb; 14():12. PubMed ID: 25889305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia.
    Oh PC; Koh KK; Sakuma I; Lim S; Lee Y; Lee S; Lee K; Han SH; Shin EK
    Int J Cardiol; 2014 Oct; 176(3):696-702. PubMed ID: 25147070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.
    Skulas-Ray AC; Kris-Etherton PM; Harris WS; Vanden Heuvel JP; Wagner PR; West SG
    Am J Clin Nutr; 2011 Feb; 93(2):243-52. PubMed ID: 21159789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.
    Wong AT; Chan DC; Ooi EM; Ng TW; Watts GF; Barrett PH
    Clin Sci (Lond); 2013 Mar; 125(1):45-51. PubMed ID: 23356247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in subjects with primary hypercholesterolemia.
    Maki KC; Lawless AL; Kelley KM; Dicklin MR; Kaden VN; Schild AL; Rains TM; Marshall JW
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):489-94. PubMed ID: 21297494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: Reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects.
    Ahn HY; Kim M; Ahn YT; Sim JH; Choi ID; Lee SH; Lee JH
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):724-33. PubMed ID: 26044516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short communication: effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia.
    Paranandi A; Asztalos BF; Mangili A; Kuvin J; Gerrior J; Sheehan H; Skinner SC; Tang AM; Wanke CA
    AIDS Res Hum Retroviruses; 2014 Aug; 30(8):800-5. PubMed ID: 24988179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.